Engineering Proteins Containing Noncanonical Amino Acids on the Yeast Surface

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2022 Apr 28

PMID 35482204

Authors

Rebecca L Hershman

Arlinda Rezhdo

Jessica T Stieglitz

James A Van Deventer

Affiliations

Soon will be listed here.

Abstract

Yeast display has been used to advance many critical research areas, including the discovery of unique protein binders and biological therapeutics. In parallel, noncanonical amino acids (ncAAs) have been used to tailor antibody-drug conjugates and enable discovery of therapeutic leads. Together, these two technologies have allowed for generation of synthetic antibody libraries, where the introduction of ncAAs in yeast-displayed proteins allows for library screening for therapeutically relevant targets. The combination of yeast display with genetically encoded ncAAs increases the available chemistry in proteins and advances applications that require high-throughput strategies. In this chapter, we discuss methods for displaying proteins containing ncAAs on the yeast surface, generating and screening libraries of proteins containing ncAAs, preparing bioconjugates on the yeast surface in large scale, generating and screening libraries of aminoacyl-tRNA synthetases (aaRSs) for encoding ncAAs by using reporter constructs, and characterizing ncAA-containing proteins secreted from yeast. The experimental designs laid out in this chapter are generalizable for discovery of protein binders to a variety of targets and aaRS evolution to continue expanding the genetic code beyond what is currently available in yeast.

Citing Articles

Reaching New Heights in Genetic Code Manipulation with High Throughput Screening.

Lino B, Williams S, Castor M, Van Deventer J Chem Rev. 2024; 124(21):12145-12175.

PMID: 39418482 PMC: 11879460. DOI: 10.1021/acs.chemrev.4c00329.

Design, Construction, and Validation of a Yeast-Displayed Chemically Expanded Antibody Library.

Rezhdo A, Hershman R, Van Deventer J bioRxiv. 2024; .

PMID: 38853888 PMC: 11160716. DOI: 10.1101/2024.05.29.596443.

Systematic Evaluation of Protein-Small Molecule Hybrids on the Yeast Surface.

Huang M, Rueda-Garcia M, Harthorn A, Hackel B, Van Deventer J ACS Chem Biol. 2024; 19(2):325-335.

PMID: 38230650 PMC: 11146673. DOI: 10.1021/acschembio.3c00524.

Strategies for enriching and characterizing proteins with inhibitory properties on the yeast surface.

Rezhdo A, Lessard C, Islam M, Van Deventer J Protein Eng Des Sel. 2023; 36.

PMID: 36648434 PMC: 10365883. DOI: 10.1093/protein/gzac017.

Yeast Display Enables Identification of Covalent Single-Domain Antibodies against Botulinum Neurotoxin Light Chain A.

Alcala-Torano R, Islam M, Cika J, Lam K, Jin R, Ichtchenko K ACS Chem Biol. 2022; 17(12):3435-3449.

PMID: 36459441 PMC: 10065152. DOI: 10.1021/acschembio.2c00574.

References

Van Deventer J, Le D, Zhao J, Kehoe H, Kelly R . A platform for constructing, evaluating, and screening bioconjugates on the yeast surface. Protein Eng Des Sel. 2016; 29(11):485-494. PMC: 5081042. DOI: 10.1093/protein/gzw029. View

Cherf G, Cochran J . Applications of Yeast Surface Display for Protein Engineering. Methods Mol Biol. 2015; 1319:155-75. PMC: 4544684. DOI: 10.1007/978-1-4939-2748-7_8. View

Galan A, Comor L, Horvatic A, Kules J, Guillemin N, Mrljak V . Library-based display technologies: where do we stand?. Mol Biosyst. 2016; 12(8):2342-58. DOI: 10.1039/c6mb00219f. View

Bradbury A, Sidhu S, Dubel S, McCafferty J . Beyond natural antibodies: the power of in vitro display technologies. Nat Biotechnol. 2011; 29(3):245-54. PMC: 3057417. DOI: 10.1038/nbt.1791. View

Bowers P, Horlick R, Neben T, Toobian R, Tomlinson G, Dalton J . Coupling mammalian cell surface display with somatic hypermutation for the discovery and maturation of human antibodies. Proc Natl Acad Sci U S A. 2011; 108(51):20455-60. PMC: 3251138. DOI: 10.1073/pnas.1114010108. View

Boder E, Raeeszadeh-Sarmazdeh M, Price J . Engineering antibodies by yeast display. Arch Biochem Biophys. 2012; 526(2):99-106. DOI: 10.1016/j.abb.2012.03.009. View

Islam M, Kehoe H, Lissoos J, Huang M, Ghadban C, Berumen Sanchez G . Chemical Diversification of Simple Synthetic Antibodies. ACS Chem Biol. 2021; 16(2):344-359. PMC: 8096149. DOI: 10.1021/acschembio.0c00865. View

Denard C, Paresi C, Yaghi R, McGinnis N, Bennett Z, Yi L . YESS 2.0, a Tunable Platform for Enzyme Evolution, Yields Highly Active TEV Protease Variants. ACS Synth Biol. 2021; 10(1):63-71. DOI: 10.1021/acssynbio.0c00452. View

Podracky C, An C, DeSousa A, Dorr B, Walsh D, Liu D . Laboratory evolution of a sortase enzyme that modifies amyloid-β protein. Nat Chem Biol. 2021; 17(3):317-325. PMC: 7904614. DOI: 10.1038/s41589-020-00706-1. View

10.

Chao G, Lau W, Hackel B, Sazinsky S, Lippow S, Wittrup K . Isolating and engineering human antibodies using yeast surface display. Nat Protoc. 2007; 1(2):755-68. DOI: 10.1038/nprot.2006.94. View

11.

Chen T, de Picciotto S, Hackel B, Wittrup K . Engineering fibronectin-based binding proteins by yeast surface display. Methods Enzymol. 2013; 523:303-26. DOI: 10.1016/B978-0-12-394292-0.00014-X. View

12.

Bacon K, Blain A, Bowen J, Burroughs M, McArthur N, Menegatti S . Quantitative Yeast-Yeast Two Hybrid for the Discovery and Binding Affinity Estimation of Protein-Protein Interactions. ACS Synth Biol. 2021; 10(3):505-514. DOI: 10.1021/acssynbio.0c00472. View

13.

Walker O, Elsasser S, Mahesh M, Bachman M, Balasubramanian S, Chin J . Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes. J Am Chem Soc. 2016; 138(3):718-21. PMC: 4821487. DOI: 10.1021/jacs.5b07627. View

14.

Zhao J, Burke A, Green A . Enzymes with noncanonical amino acids. Curr Opin Chem Biol. 2020; 55:136-144. DOI: 10.1016/j.cbpa.2020.01.006. View

15.

Panowski S, Bhakta S, Raab H, Polakis P, Junutula J . Site-specific antibody drug conjugates for cancer therapy. MAbs. 2014; 6(1):34-45. PMC: 3929453. DOI: 10.4161/mabs.27022. View

16.

Axup J, Bajjuri K, Ritland M, Hutchins B, Kim C, Kazane S . Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. Proc Natl Acad Sci U S A. 2012; 109(40):16101-6. PMC: 3479532. DOI: 10.1073/pnas.1211023109. View

17.

Budisa N, Schneider T . Expanding the DOPA Universe with Genetically Encoded, Mussel-Inspired Bioadhesives for Material Sciences and Medicine. Chembiochem. 2019; 20(17):2163-2190. DOI: 10.1002/cbic.201900030. View

18.

Tian F, Lu Y, Manibusan A, Sellers A, Tran H, Sun Y . A general approach to site-specific antibody drug conjugates. Proc Natl Acad Sci U S A. 2014; 111(5):1766-71. PMC: 3918752. DOI: 10.1073/pnas.1321237111. View

19.

Bhakta S, Raab H, Junutula J . Engineering THIOMABs for site-specific conjugation of thiol-reactive linkers. Methods Mol Biol. 2013; 1045:189-203. DOI: 10.1007/978-1-62703-541-5_11. View

20.

Rezhdo A, Islam M, Huang M, Van Deventer J . Future prospects for noncanonical amino acids in biological therapeutics. Curr Opin Biotechnol. 2019; 60:168-178. PMC: 6783319. DOI: 10.1016/j.copbio.2019.02.020. View